April 6, 2026 | View as Webpage

CEO Message

MedChi Files Amicus Brief to Uphold Law Preventing Excessive Physician Lawsuits


The Litigation Center of the American Medical Association and State Medical Societies and the Maryland State Medical Society (MedChi), filed an amicus brief in the U.S. Supreme Court urging the Court to uphold case law that stops plaintiffs from filing parallel medical liability lawsuits in state and federal courts.


The high court is set to hear oral arguments on April 20 in a case that aims to change how the Rooker-Feldman doctrine is applied. For years, that doctrine has allowed only the U.S. Supreme Court—not lower federal courts—to review state court decisions after the state’s highest court has issued a judgment or decree, and only in situations where plaintiffs complain of injuries caused by state court judgments before the federal court proceedings began.


The plaintiff in the case before the Supreme Court, T.M. v. University of Maryland Medical System Corp. et al., filed a federal lawsuit at the same time she was appealing a consent decree to a state appellate court. She claims the Rooker-Feldman doctrine only applies after state-court proceedings have ended, so federal court challenges to ongoing state malpractice litigation shouldn’t be barred.


T.M. has a rare condition that can cause temporary psychosis. After an episode in 2023, she was involuntarily committed to a state hospital and was then forcibly medicated. She alleged that the state consent order that dictated her treatment plan going forward violated her constitutional rights. The federal district court dismissed T.M.’s federal claim, citing the Rooker-Feldman doctrine. The 4th U.S. Circuit Court of Appeals affirmed that decision, and now T.M. has appealed that decision to the U.S. Supreme Court.


In their amicus brief, the AMA Litigation Center and MedChi urge the Supreme Court to uphold the court of appeals decision dismissing the federal lawsuit under the Rooker-Feldman doctrine. They say that nowhere in the case law “did the Court mandate a ‘stealth fifth requirement’ that for Rooker-Feldman to apply, the state court judgment at issue cannot be subject to further state-court review.” In fact, the brief says, the U.S. Supreme Court and circuit courts have previously said that the doctrine applies to state court judgments that aren’t final yet.


Overturning the 4th Circuit’s opinion and allowing the federal claim to move forward while a state claim was pending “would encourage plaintiffs with baseless medical malpractice claims to pursue parallel litigation in state and federal courts to run up legal fees and extract nuisance settlements. It would also invite frivolous state court appeals for the purpose of keeping federal cases that would otherwise be dead-on-arrival alive, if only temporarily,” the AMA Litigation Center and MedChi tell the court in their amicus brief, saying that “the court should eschew such a result.”


MedChi President, Dr. Eric Wargotz, stated that, “MedChi is fighting to ensure the legal system is not used to harass physicians with meritless claims that drain resources from patient care.” Dr. Wargotz emphasized that "these legal battles, which can be costly even when dismissed, contribute to physician burnout and threaten public health.”


If plaintiffs can file a federal lawsuit after a state court judgement isn’t one that they like, the secondary lawsuit will be duplicative except for the constitutional claims that are added to the federal lawsuit, even if there is no reason why the constitutional claims could not have been included in the original state court claim.


“As this court has long recognized, state courts are no less duty-bound, or adept at, protecting federal constitutional rights than federal courts,” the brief says. “Nevertheless, the transparent motivation behind filing a second lawsuit in federal court is to attempt to get the district court to reverse the adverse state court ruling. Rooker-Feldman forbids this result.”


These extra lawsuits would just add to the burden of frivolous lawsuits that physicians face, lawsuits that take money away from patient care and add to physician burnout. The AMA Litigation Center and MedChi tell the court of a study that looked at all medical malpractice claims closed between 2002 and 2005, and that involved some defense cost. This study showed that more than 54% of litigated claims were dismissed. Among the cases that went to trial, 80% were decided in the physician’s favor.


And those numbers have only gone up. A study (PDF) published in 2019 found that 65% of claims resolved between 2016 and 2018 were dropped, dismissed or withdrawn and defendants won 89% of cases decided after a trial.


Even if lawsuits are decided in physicians’ favor, it is costly to defend claims. The average defense cost for settled claims that closed between 2016 and 2018 was $77,117 according to the Medical Professional Liability Association’s Data Sharing Project. Meanwhile, for tried claims, it was $158,843 when there was a defendant victory and $236,519 for a plaintiff victory. When claims were dropped, dismissed or withdrawn, the average defense cost was $30,439.


The AMA Litigation Center and MedChi tell the court that “Rooker-Feldman thus remains an 

important safeguard against what empirical research suggests is an increasing percentage of 

meritless medical malpractice claims.”

Gene M. Ransom III

CEO

MedChi, The Maryland State Medical Society


Advocacy: Your Voice Matters

Upcoming Events

News & Resources

When to Review Your Medical Practice Insurance Coverage


As medical practices grow and evolve, keeping insurance coverage aligned with operational changes helps prevent complications and ensures protection keeps pace.

CDC Health Alert Network issues Advisory about Medetomidine

 

The U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory this morning about medetomidine being increasingly found in the illegal drug supply. Medetomidine, which is not approved for human use, “can cause profound sedation, bradycardia, and hypotension. Stopping medetomidine following regular use may lead to severe withdrawal, similar to clonidine withdrawal, with symptoms including hypertension, anxiety, nausea, vomiting, and fluctuating alertness, that can require emergency or intensive care,” according to the CDC. The CDC further advises that “because fentanyl is involved in most overdoses involving medetomidine, opioid overdose reversal medications (e.g., naloxone) should be administered to restore normal breathing in suspected overdoses.”

 

The full HAN advisory provides additional information, resources and detailed recommendations for clinicians, public health professionals, laboratories and people at risk of overdose. Read the full HAN medetomidine advisory here.

MedCast Special Edition Podcast


The Maryland State Medical Society (MedChi) brings a special edition of MedCast to its members and the public. This recording of the 2026 Carol & Dr. Thomas Allen Annual Ethics Lecture on "Vaccine Mandates Ethical & Legal Perspectives" featuries three distinguished guests: Nicole Cimino-Fiallos, MD, an Emergency Medicine physician at Mid-Atlantic Permanente Group; Mark Graber, JD, PHD, a professor at the University of Maryland; and Greg Dolin, MD, JD, a professor at the University of Baltimore School of Law. The lecture was hosted by David Hexter, MD, Chair, Committee on Ethics and Judicial Affairs at MedChi. Introductions were given by Elizabeth Keyes, JD, Associate Dean at the University of Maryland School of Law, and Eric Wargotz, MD, President of MedChi. Listen now.

Physicians in the News

Easton Dermatology Associates Is First in Talbot County to Offer Nonsurgical Treatment for Common Skin Cancer


MedChi Members Dr. Michael A. Del Torto and Dr. Donald Stranahan, and SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC announced that Easton Dermatology Associates is the First in Talbot County to offer nonsurgical treatment for common skin cancer. Click here for more.

Lotus Oncology & Hematology Expands to New Satellite Location


MedChi Member and Talbot County Medical Society President Dr. Roopa Gupta is excited to share that Lotus Oncology & Hematology has expanded their practice so patients across the Eastern Shore can receive care closer to home. Their new satellite office is located at 130 Love Point Road in Stevensville, Maryland.

If you have news to share about yourself, a colleague, or your practice, and would like us to feature it in MedChi News,

please contact Olivia Ballmann. All submissions are subject to review and approval.

Submission does not guarantee inclusion, publication, or use.

Member Opportunities

Sign Up Now for MedChi’s 2026 Doctor of the Day!


MedChi has the unique privilege of being able to coordinate physicians to serve in the Maryland State House First Aid Room during each General Assembly Session. Now is your chance to volunteer for the 2026 session. Sign up here. Questions? Contact Hamida Mansaray at hmansaray@medchi.org or call 410-878-9599.

Now Accepting Applications for the NHSC Scholarship Program


The National Health Service Corps (NHSC) Scholarship Program awards scholarships to students pursuing eligible primary care health professions training. In return, you commit to providing primary care health services in a Health Professional Shortage Area for a minimum of two years or a maximum of four years of service. Accepting applications through Thursday, April 16 at 7:30 P.M. Click here to learn more.

Learn About Caring One's Services Today!


Caring One’s 24/7 RN staffed call center delivers premium, clinically trained support that improves patient communication while giving practices instant access to licensed RN/BSN professionals. Caring One empowers practices to boost patient satisfaction, reduce burnout, and modernize operations with confidence. Click here for more.

This Week's Sponsor

Thank you for your support!

Your Advocate. Your Resource. Your Profession.

We Want to Hear From You!

Click here to share your news, suggestions, & ideas!

MedChi, The Maryland State Medical Society

800.492.1056 • www.medchi.org

Email  Facebook  Instagram  LinkedIn  Web  X  YouTube